HUMANA INC

Humana’s 10‑Q shows a steady asset base, a modest operating loss, and a strategic MaxHealth acquisition driving integrated primary‑care expansion and tech‑enabled cost‑saving initiatives.

Humana’s 2026 Q3 results show 1.9% revenue growth, a 94.2% benefit ratio, and a 63.8% operating‑cost ratio—boosting GAAP EPS guidance and fueling a digital‑health, CenterWell expansion strategy.

Humana Inc. Q1 2027: robust growth, stable NIM & loss ratios, new card platform & Canadian exit, driving value‑creation for healthcare‑financing investors.

Humana Inc’s Q1 2027 earnings show steady growth, cost‑to‑income cut to 39.9%, and strategic pull‑out of Canada to boost Irish and UK returns.